Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China.|https://dx.doi.org/10.3389/fmed.2024.1461801
Community-led diphtheria vaccination campaign to manage a diphtheria outbreak in a remote Aboriginal community.|https://dx.doi.org/10.33321/cdi.2024.48.49
Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults.|https://dx.doi.org/10.1093/cid/ciae519
Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.|https://dx.doi.org/10.1111/irv.70013
Challenges of Infectious Diseases in Older Adults: From Immunosenescence and Inflammaging Through Antibiotic Resistance to Management Strategies.|https://dx.doi.org/10.1016/j.mad.2024.111998
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study.|https://dx.doi.org/10.1093/infdis/jiae466
Multivalent vaccine tackles C. difficile.|https://dx.doi.org/10.1038/d41573-024-00174-5
Novel coenzyme Q6 genetic variant increases susceptibility to pneumococcal disease.|https://dx.doi.org/10.1038/s41590-024-01998-4
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK.|https://dx.doi.org/10.1111/irv.70014
